UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus

Nature reviews. Endocrinology, 2012-12, Vol.8 (12), p.728

Meier, Juris J

2012

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Semaglutide in a Subcutaneous and an Oral Formulation

Frontiers in endocrinology (Lausanne), 2021-06, Vol.12, p.645617

Meier, Juris J

2021

Link zum Volltext

Verfügbarkeit prüfen

GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art

Molecular metabolism (Germany), 2021-04, Vol.46, p.101102-101102, Article 101102

2021

Link zum Volltext

Verfügbarkeit prüfen

The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions

The lancet. Diabetes & endocrinology, 2016-06, Vol.4 (6), p.525-536

2016

Link zum Volltext

Verfügbarkeit prüfen

GIP and GLP-1: Stepsiblings Rather Than Monozygotic Twins Within the Incretin Family

Diabetes (New York, N.Y.), 2019-05, Vol.68 (5), p.897-900

2019

Link zum Volltext

Verfügbarkeit prüfen

Incretin‐based glucose‐lowering medications and the risk of acute pancreatitis and malignancies: a meta‐analysis based on cardiovascular outcomes trials

Diabetes, obesity & metabolism, 2020-04, Vol.22 (4), p.699-704

2020

Link zum Volltext

Verfügbarkeit prüfen

A meta‐analysis comparing clinical effects of short‐ or long‐acting GLP‐1 receptor agonists versus insulin treatment from head‐to‐head studies in type 2 diabetic patients

Diabetes, obesity & metabolism, 2017-02, Vol.19 (2), p.216-227

2017

Link zum Volltext

Verfügbarkeit prüfen

Rapid Tachyphylaxis of the Glucagon-Like Peptide 1-Induced Deceleration of Gastric Emptying in Humans

Diabetes (New York, N.Y.), 2011-05, Vol.60 (5), p.1561-1565

2011

Link zum Volltext

Verfügbarkeit prüfen

Diabetes and Aging: From Treatment Goals to Pharmacologic Therapy

Frontiers in endocrinology (Lausanne), 2019-02, Vol.10, p.45-45

2019

Link zum Volltext

Verfügbarkeit prüfen

SGLT-2 Inhibition and the Endocrine Pancreatic Alpha Cell: Direct or Indirect Mechanisms of Inhibition?

Endocrinology (Philadelphia), 2020-08, Vol.161 (8), p.1

2020

Link zum Volltext

Verfügbarkeit prüfen

β-Cell Replication Is the Primary Mechanism Subserving the Postnatal Expansion of β-Cell Mass in Humans

Diabetes (New York, N.Y.), 2008-06, Vol.57 (6), p.1584-1594

2008

Link zum Volltext

Verfügbarkeit prüfen

Statistical power for MACE and individual secondary endpoints in cardiovascular outcomes trials for type 2 diabetes: a systematic review

Scientific reports, 2022-12, Vol.12 (1), p.21069-21069

2022

Link zum Volltext

Verfügbarkeit prüfen

Safety and tolerability of semaglutide across the SUSTAIN and PIONEER phase IIIa clinical trial programmes

Diabetes, obesity & metabolism, 2023-05, Vol.25 (5), p.1385-1397

2023

Link zum Volltext

Verfügbarkeit prüfen

The importance of glucose-dependent insulinotropic polypeptide receptor activation for the effects of tirzepatide

Diabetes, obesity & metabolism, 2023-11, Vol.25 (11), p.3079-3092

2023

Link zum Volltext

Verfügbarkeit prüfen

Predictors of Incretin Concentrations in Subjects With Normal, Impaired, and Diabetic Glucose Tolerance

Diabetes (New York, N.Y.), 2008-03, Vol.57 (3), p.678-687

2008

Link zum Volltext

Verfügbarkeit prüfen

Incretin hormones: Their role in health and disease

Diabetes, obesity & metabolism, 2018-02, Vol.20 (S1), p.5-21

2018

Link zum Volltext

Verfügbarkeit prüfen

Importance of localization of insulinomas: a systematic analysis

Journal of hepato-biliary-pancreatic sciences, 2019-09, Vol.26 (9), p.383-392

2019

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Reviews and Novel Clinical Perspectives on Semaglutide: A GLP-1 Receptor Agonist With Both Injectable and Oral Formulations

Frontiers in endocrinology (Lausanne), 2021-09, Vol.12, p.760153-760153

2021

Link zum Volltext

Verfügbarkeit prüfen

Gut microbiota differs in composition between adults with type 1 diabetes with or without depression and healthy control participants: a case-control study

BMC microbiology, 2022-06, Vol.22 (1), p.1-169, Article 169

2022

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic accuracy of an "amended" insulin-glucose ratio for the biochemical diagnosis of insulinomas

Annals of internal medicine, 2012-12, Vol.157 (11), p.767

2012

Link zum Volltext

Verfügbarkeit prüfen

Hyperinsulinemic Hypoglycemia After Gastric Bypass Surgery Is Not Accompanied by Islet Hyperplasia or Increased β-Cell Turnover

Diabetes care, 2006-07, Vol.29 (7), p.1554-1559

2006

Link zum Volltext

Verfügbarkeit prüfen

Incretin‐based glucose‐lowering medications and the risk of acute pancreatitis and/or pancreatic cancer: Reassuring data from cardio‐vascular outcome trials

Diabetes, obesity & metabolism, 2017-09, Vol.19 (9), p.1327-1328

2017

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Insulin-Treated Patients with Ambiguous Diabetes Type with Definite Type 1 and Type 2 Diabetes Mellitus Subjects: A Clinical Perspective

Diabetes & metabolism journal, 2023-01, Vol.47 (1), p.140-146

2023

Link zum Volltext

Verfügbarkeit prüfen

Treatment of type 2 diabetes: challenges, hopes, and anticipated successes

The lancet. Diabetes & endocrinology, 2021-08, Vol.9 (8), p.525-544

2021

Link zum Volltext

Verfügbarkeit prüfen

Pulsatile Insulin Secretion Dictates Systemic Insulin Delivery by Regulating Hepatic Insulin Extraction In Humans

Diabetes (New York, N.Y.), 2005-06, Vol.54 (6), p.1649-1656

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 238

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(203)
Mit Volltextzugriff
(221)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(161)
Life Sciences & Biomedicine
(159)
Humans
(146)
Endocrinology & Metabolism
(125)
Diabetes
(82)
Male
(74)
Female
(69)
Biological And Medical Sciences
(62)
Middle Aged
(57)
Medical Sciences
(55)
Adult
(51)
Glucose
(49)
Insulin
(48)
Type 2 Diabetes
(48)
Diabetes Mellitus, Type 2 - Drug Therapy
(43)
Endocrinopathies
(42)
Aged
(39)
Endocrine Pancreas. Apud Cells
(38)
Glucagon
(37)
Diabetes. Impaired Glucose Tolerance
(35)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus

Efficacy of Semaglutide in a Subcutaneous and an Oral Formulation

GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art

The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions

GIP and GLP-1: Stepsiblings Rather Than Monozygotic Twins Within the Incretin Family

Incretin‐based glucose‐lowering medications and the risk of acute pancreatitis and malignancies: a meta‐analysis based on cardiovascular outcomes trials

A meta‐analysis comparing clinical effects of short‐ or long‐acting GLP‐1 receptor agonists versus insulin treatment from head‐to‐head studies in type 2 diabetic patients

Rapid Tachyphylaxis of the Glucagon-Like Peptide 1-Induced Deceleration of Gastric Emptying in Humans

Diabetes and Aging: From Treatment Goals to Pharmacologic Therapy

SGLT-2 Inhibition and the Endocrine Pancreatic Alpha Cell: Direct or Indirect Mechanisms of Inhibition?

β-Cell Replication Is the Primary Mechanism Subserving the Postnatal Expansion of β-Cell Mass in Humans

Statistical power for MACE and individual secondary endpoints in cardiovascular outcomes trials for type 2 diabetes: a systematic review

Safety and tolerability of semaglutide across the SUSTAIN and PIONEER phase IIIa clinical trial programmes

The importance of glucose-dependent insulinotropic polypeptide receptor activation for the effects of tirzepatide

Predictors of Incretin Concentrations in Subjects With Normal, Impaired, and Diabetic Glucose Tolerance

Incretin hormones: Their role in health and disease

Importance of localization of insulinomas: a systematic analysis

Editorial: Reviews and Novel Clinical Perspectives on Semaglutide: A GLP-1 Receptor Agonist With Both Injectable and Oral Formulations

Gut microbiota differs in composition between adults with type 1 diabetes with or without depression and healthy control participants: a case-control study

Diagnostic accuracy of an "amended" insulin-glucose ratio for the biochemical diagnosis of insulinomas

Hyperinsulinemic Hypoglycemia After Gastric Bypass Surgery Is Not Accompanied by Islet Hyperplasia or Increased β-Cell Turnover

Incretin‐based glucose‐lowering medications and the risk of acute pancreatitis and/or pancreatic cancer: Reassuring data from cardio‐vascular outcome trials

Comparison of Insulin-Treated Patients with Ambiguous Diabetes Type with Definite Type 1 and Type 2 Diabetes Mellitus Subjects: A Clinical Perspective

Treatment of type 2 diabetes: challenges, hopes, and anticipated successes

Pulsatile Insulin Secretion Dictates Systemic Insulin Delivery by Regulating Hepatic Insulin Extraction In Humans

Suchergebnisse filtern